Txinno

Developer of therapeutics for the treatment of cancer

placeYongin Si, Gyeonggi Do, South Korea calendar_todayFounded 2020 groups25 employees language txinno.com

Social engagement

Social engagement: 280 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Company K Partners, DSC Investment, Korea Investment Holdings, Schmidt.

Investor typeCountShare
Venture capital375%
Bank & private debt125%

Recent activity

27 Apr 2026
Leadership hire
Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute
31 Mar 2026
Partnership
NaminuICT
25 Mar 2026
Event
AACR 2026 poster session on ULK1 Targeted Protein Degrader (TPD) candidate TXN12923
Coming soon